Gupta, S., Grivas, P., Park, S. H., Petrylak, D. P., Tyroller, K., Hoffman, J., Bellmunt, J. (2025). Avelumab first-line maintenance (1LM) in patients (pts) with advanced urothelial carcinoma (aUC) with or without diabetes mellitus (DM): Long-term outcomes from JAVELIN Bladder 100.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.869